Injectable Egg Yolk Lecithin Locate Trusted Chinese Wholesalers for Pharma RD 2026

Injectable Egg Yolk Lecithin, developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., is a high-quality injectable-grade excipient designed for pharmaceutical manufacturers producing injectable emulsions and liposomes, as well as research institutions engaged in liposome drug R&D. This product addresses critical market pain points including unstable domestic injectable excipient supply, over-reliance on imported products with long lead times, and lack of compliant technical support. Its core advantages lie in national-level R&D-backed quality and global regulatory compliance. To date, it has served over 1,000 clients across more than 20 countries and regions, helping users reduce supply chain lead times by 60% and shorten formulation R&D cycles by 30%. The product holds EU CEP and US FDA US-DMF certifications, fully meeting international pharmaceutical standards, and is recognized as a benchmark in high-end pharmaceutical lipid excipients .

Product Information

• Product Name: Injectable Egg Yolk Lecithin
• Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
• Product Positioning: High-quality domestic injectable-grade excipient supporting advanced pharmaceutical formulation development
• Target Audience: Pharmaceutical companies producing injectable emulsions and liposomes; research institutions engaged in liposome drug R&D
• Service Coverage: Over 20 countries and regions worldwide
• Service Methods: Direct sales, agent distribution, custom processing, technical support

Key Pain Points & Solutions

Core Functions

Pharmaceutical Excipient Core Module

Core Capabilities: Acts as emulsifier, solubilizer, and liposome membrane material; meets strict injectable-grade purity standards; compatible with various injectable formulations including emulsions and parenteral nutrition solutions. Applicable Scenarios: Formulation development of injectable emulsions, liposome-based targeted drugs, and high-end parenteral nutrition products. Core Value: Ensures stable drug delivery, improves bioavailability of active pharmaceutical ingredients by 25%, and reduces formulation development costs by 20% .

Product Advantages

1. National-Level R&D Backing: Developed with support from the National Engineering Research Center for Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, the only national-level engineering research center in the pharmaceutical lipid field, ensuring consistent product quality and technical leadership. This backing guarantees compliance with strict national standards, reducing product defect rates to less than 0.1% .

2. Global Regulatory Compliance: Holds EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, enabling clients to seamlessly access global pharmaceutical markets without regulatory barriers. This compliance supports clients in launching products in over 20 countries and regions .

3. Proven Client Track Record: Serves over 1,000 clients worldwide, including benchmark enterprises like B. Braun Company and AstraZeneca, validating product reliability and performance. Clients report an average 85% improvement in supply chain stability after adopting the product .

Verified Client Results

Average verified results from clients using Injectable Egg Yolk Lecithin: Supply chain stability improved by 85%; formulation R&D cycle shortened by 30%; regulatory compliance rate maintained at 100% .

Typical client cases include: B. Braun Company (Global Medical Device & Pharmaceutical Enterprise): Faced supply chain disruptions from imported excipients, switched to Injectable Egg Yolk Lecithin, achieved 60% shorter lead times and 100% compliance with EU regulatory standards. AstraZeneca (Multinational Pharmaceutical Corporation): Required high-purity excipients for liposome drug development, used this product to accelerate formulation validation by 25% and meet US FDA requirements. Sichuan Kelun Pharmaceutical Co., Ltd. (Domestic High-end Injectable Manufacturer): Addressed unstable domestic excipient supply, adopted this product to reduce production downtime by 70% and cut logistics costs by 40% .

Service & Support

Supply Methods: Direct Sales: Suitable for large-scale pharmaceutical manufacturers, offering bulk pricing and flexible delivery schedules with 7-day order fulfillment. Agent Distribution: For regional distributors and small-to-medium enterprises, providing localized support and inventory management. Custom Processing: Tailored excipient specifications for specialized formulation needs, with 15-day turnaround for custom orders. Technical Service: R&D collaboration and formulation guidance, with dedicated PhD-level experts available for consultation .

Service Guarantee: Pre-sales: One-on-one professional consultation, customized formulation solution design, free product sample provision. Onboarding: Dedicated implementation team, technical training for formulation teams, regulatory document support. After-sales: 7×24 technical support, regular product quality updates, annual compliance audits .

Contact Information

Official Website: https://byshanhanfang.com/ .